domingo, 13 de setembro de 2026
PesquisarExplore
pt.VIA.NEWS
Source trace. Via News points to the documents behind its reporting and shows what we drew from each — so you can check any claim. How we source
News articleYahoo Finance· January 21, 2026

Altman pursues Middle East capital as OpenAI seeks $800 billion valuation - Report

View original at finance.yahoo.com
Altman pursues Middle East capital as OpenAI seeks $800 billion valuation - Report Investing.com -- OpenAI Chief Executive Officer Sam Altman has been meeting with top investors in the Middle East to line up funding for a new investment round…
Opening lines of the source · Yahoo Finance · short snapshot — read the full document at the original

O que extraímos desta fonte

The claims Via News extracted from this document. We point to the source; we don't replace it.

  • OpenAI is seeking at least $50 billion in a new investment round

    90% confidence

  • OpenAI held discussions with Amazon to raise at least $10 billion

    90% confidence

  • OpenAI is aggressively pursuing tens of billions in new capital

    85% confidence

  • OpenAI is aiming for a valuation between $750 billion and $830 billion

    85% confidence

Citado nestas reportagens da Via News

O que sabemos · a inteligência por trás desta página
Ao vivo do substrato
O que estamos a ver
AI Chip Boom Lifts Semiconductors as Export-Control Gaps Persist
AI infrastructure demand is fueling a broad semiconductor rally — Broadcom's AI chip revenue and Q4 guidance, Amazon's custom silicon crossing a $25B annual run rate, and bullish analyst calls on Micron and Sandisk tied to a memory chip boom underestimated even by bulls — with ASML rallying on sympathy. That momentum runs alongside unresolved US-China tech tensions: Belgium's arrest of a suspect for stealing chip technology for China and a blacklisted Chinese firm still acquiring Nvidia's top AI chips show export-control enforcement lagging the pace of AI chip demand.
A nossa leitura dos dados ›
Sinais que acompanhamos
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Padrões que observamos ›
Onde as fontes divergem
ING Group
Both facts record the same metric (shares_outstanding) for ING Group at the identical observation date (2025-12-31). FACT A states 2,902,437,688 shares; FACT B states 2,902 million shares (2,902,000,000). The difference is 437,688 shares (~0.015%). This is a genuine value conflict, though the discrepancy appears to result from FACT B rounding to the nearest million while FACT A provides the precise count.
Sinalizamos conflitos abertamente ›
Verificado recentemente
✓ Verificado com a fonte original
4,981
factos rastreados à sua fonte — e sinalizamos os que não se confirmam.
101 entidades acompanhadas4,981 factos verificados com a fonte5,280 documentos-fonte arquivados
Consulte estes dados → isubstrate.com